Asia-Pacific Nuclear Imaging Market to touch USD 5.43 billion by 2022 | Market DPosted by rohan on February 20th, 2018 According to the report Asia-Pacific Nuclear Imaging Market, published by Market Data Forecast, the market is projected to reach USD 5.43 billion by 2022, at a CAGR of 9.64% from 2017 to 2022. Nuclear Imaging is the process of capturing images by tracing radiation after a radioactive material being administered at the specific part of the body that should be diagnosed by the physician. It is different from other radiologic tests by evaluating how the organ functions rather than only showcasing image. The radiation received by the patient during the scan will be very low that do not affect any body part. With growing prevalence of chronic diseases, there is a huge market for the nuclear imaging in the forecast period. Get a comprehensive overview of the Asia-Pacific Nuclear Imaging Market: https://www.marketdataforecast.com/market-reports/asia-pacific-nuclear-imaging-market-1626/ Asia-Pacific Nuclear Imaging Market: Drivers & Restraints Factors such as rise in cancer and cardiovascular incidences, improved healthcare infrastructure, demand for minimally invasive procedures, growth in radiopharmaceuticals, favourable government policies, new product innovations and technology advancements in the healthcare sector are driving for the growth of the Asia-Pacific Nuclear Imaging market. However, high cost equipment and lack of trained staff are hindering the growth of the Asia-Pacific Nuclear Imaging Market. Get accurate market forecast and analysis on the Asia-Pacific Nuclear Imaging Market. Request a sample to stay up-to-date on the main trends affecting this market: https://www.marketdataforecast.com/market-reports/asia-pacific-nuclear-imaging-market-1626/request-sample Asia-Pacific Nuclear Imaging Market: Segmentation By Diagnostic Technologies
By Application
By Geography
Asia-Pacific Nuclear Imaging Market: Overview In 2017, PET Radioisotopes has the largest share in terms of revenue due to it is mainly being utilized in oncology owing to superior quality of imaging. Meanwhile, SPECT is growing at a high pace because in cardiology section, it is accounting for almost 80% of the entire cardiology market share. In application, Oncology and Cardiology accounts for the highest share in the global market. The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Asia-Pacific is expected to grow rapidly in the coming years as is evident from the high CAGR value for the region due to growing healthcare industry, rising popularity of several radiopharmaceuticals in many applications and emerging economies like China and India. Asia-Pacific Nuclear Imaging Market: Key Players The major companies in the Asia-Pacific Nuclear Imaging market are Siemens Medical Solutions, General Electric and Philips Medical Systems. Other companies include Hitachi Medical Corporation, Lantheus Medical Imaging Inc., Toshiba Medical Systems Corporation, Carestream Health, Mallinckrodt plc, Medtronic Inc., Positron Corporation, Bayer AG and IBA Group. About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com
Like it? Share it! More by this author |